Lamivudine prophylaxis for hepatitis B virus carrier patients with breast cancer during adjuvant chemotherapy-Reference-Cited by-同舟云学术

Lamivudine prophylaxis for hepatitis B virus carrier patients with breast cancer during adjuvant chemotherapy

Published:2012-10-17 Issue:4 Volume:21 Page:387-393
ISSN:1340-6868
Container-title:Breast Cancer
language:en
Short-container-title:Breast Cancer

Author:

Lee Hyun Jung,Kim Dae Young,Keam Bhumsuk,Lee Jeong Hoon,Han Sae-Won,Oh Do-Youn,Yoon Jung Hwan,Kim Tae-You,Kim Yu Jung,Lee Keun Wook,Kim Jin-Wook,Jeong Sook-Hyang,Lee Jong Seok,Kim Jee Hyun,Im Seock-Ah

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Radiology Nuclear Medicine and imaging,Oncology,General Medicine

Link

http://link.springer.com/content/pdf/10.1007/s12282-012-0417-3.pdf

Reference22 articles.

1. Lok AS, Liang RH, Chiu EK, Wong KL, Chan TK, Todd D. Reactivation of hepatitis B virus replication in patients receiving cytotoxic therapy. Report of a prospective study. Gastroenterology. 1991;100(1):182–8.

2. Kumagai K, Takagi T, Nakamura S, Sawada U, Kura Y, Kodama F, et al. Hepatitis B virus carriers in the treatment of malignant lymphoma: an epidemiological study in Japan. Ann Oncol. 1997;8(suppl 1):S107.

3. Liang R, Lau GKK, Kwong Y. Chemotherapy and bone marrow transplantation for cancer patients who are also chronic hepatitis B carriers: a review of the problem. J Clin Oncol. 1999;17(1):394.

4. Yeo W, Chan PK, Zhong S, Ho WM, Steinberg JL, Tam JS, et al. Frequency of hepatitis B virus reactivation in cancer patients undergoing cytotoxic chemotherapy: a prospective study of 626 patients with identification of risk factors. J Med Virol. 2000;62(3):299–307.

5. Yeo W, Zee B, Zhong S, Chan PK, Wong WL, Ho WM, et al. Comprehensive analysis of risk factors associating with Hepatitis B virus (HBV) reactivation in cancer patients undergoing cytotoxic chemotherapy. Br J Cancer. 2004;90(7):1306–11.

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Hepatitis B Virus Reactivation in Cancer Patients Receiving Chemotherapy—A Systematic Review and Meta-Analysis;Seminars in Oncology;2024-08

2. Acute liver failure due to hepatitis B virus reactivation induced by doxorubicin and cyclophosphamide chemotherapy for adjuvant treatment of breast cancer: A case report;Clinical Case Reports;2022-05

3. APASL clinical practice guideline on hepatitis B reactivation related to the use of immunosuppressive therapy;Hepatology International;2021-08-24

4. Hepatitis B Virus Reactivation;Clinics in Liver Disease;2020-08

5. Palbociclib and ribociclib in breast cancer: consensus workshop on the management of concomitant medication;Therapeutic Advances in Medical Oncology;2019-01